Clinical Policy and Guidance

  1. Use of attendance items (MBS 104 and 105) in relation to cosmetic procedures
    In August 2013 the Government provided ASPS with official clinical guidance on the use of MBS Items 104 and 105 in relation to cosmetic procedures. ASPS Fees Committee has produced a clinical guidance for members information.
    Download the clinical guidance.
  2. Schedule 4 injectables and nurse injectors
    In September 2012, ASPS Council approved a public position statement on the administration of shcedule 4 prescription medicines (for example, Botulinum Toxin)  by nurse injectors.
    Download the position statement. Read more in our current issues article called Who is qualified to inject fillers and wrinkle treatments?